99 reports

  • GLOBAL CANCER IMMUNOTHERAPIES MARKET BY TYPE OF CANCER IMMUNOTHERAPIES 2015
  • CANCER IMMUNOTHERAPIES MARKET IN AMERICAS

About Cancer Immunotherapies Cancer immunotherapy works by enhancing the innate powers of the immune system. This has better chances of successfully fighting cancer for a long period. Also, immunotherapies have fewer side effects and can treat different types of cancer. Cancer immunotherapies make up nearly 50% of the cancer drugs...

  • Cancer Immunotherapy
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd.
  • Merck & Co., Inc.

Global Cancer Immunotherapy Market to 2027 ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

## Global Cancer Immunotherapy Market Outlook, By Region (2014-2023) ($MN) Table ## Global Cancer Immunotherapy Market Outlook, By Product Type (2014-2023) ($MN) Table ## Global Cancer Immunotherapy Market Outlook, By Immune Checkpoint Inhibitors (2014-2023) ($MN) Ta

  • Cancer Immunotherapy
  • Therapy
  • World
  • Forecast
  • CANCER IMMUNOTHERAPY ARTIFICIAL INTELLIGENCE MARKET SHARES,
  • CANCER IMMUNOTHERAPY ARTIFICIAL INTELLIGENCE SYSTEMS, REGIONAL

Hospital Artificial Intelligence for Immunotherapy drives sales of analytics systems. Automated cancer immunotherapies from IBM Watson are implemented with artificial intelligence that looks at patient samples to detect the genetic characteristics of the cancer and isolate the immune particularities of the patient. Systems are able...

  • Cancer Immunotherapy
  • Foundation Medicine, Inc.
  • GE Healthcare Limited
  • General Electric Company
  • NVIDIA Corporation

PD-##/ PD-L## ##. ##. ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • APAC
  • World
  • Market Size

##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size
  • A) Cancer immunotherapies market size
  • CANCER IMMUNOTHERAPIES MARKET, GLOBAL, PIPELINE FOR CANCER IMMUNOTHERAPIES BY

Global Cancer Immunotherapies Market to 2022 - Immune Checkpoint Inhibitors and Therapeutic Cancer Vaccines to Characterize Increasingly Competitive Market Summary Cancer is a group of diseases characterized by abnormal cell growth. It is a multi-step process, as a single mutation is almost certainly insufficient to cause...

  • Cancer Immunotherapy
  • World
  • Market Size
  • Celgene Corporation
  • Merck & Co., Inc.

Global Cancer Immunotherapy Market & Clinical Trials Outlook 2022 ##.

  • Cancer Immunotherapy
  • Therapy
  • World

Cancer Immunotherapy Market - Global Opportunity Analysis and Industry Forecast, 2014-2022 CHAPTER ## INTRODUCTION ##. ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Global Cancer Immunotherapy Market Analysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size

Cancer immunotherapy market, by cancre type, 2014 - 2025 (USD Billion) TABLE ## Canada Cancer immunotherapy market, by product, 2014 - 2025 (USD Billion) TABLE ## Canada Cancer immunotherapy market, by cancre type, 2014 - 2025 (USD Billion) TABLE ## Europe

  • Cancer Immunotherapy
  • Therapy
  • United States
  • Forecast
  • Market Size

Europe Cancer Immunotherapy MarketAnalysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • Europe
  • United States
  • Market Size

LAMEA Cancer Immunotherapy MarketAnalysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Oncology
  • Therapy
  • United States
  • Market Size

Asia Pacific Cancer Immunotherapy MarketAnalysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • APAC
  • United States
  • Market Size

North America Cancer Immunotherapy MarketAnalysis (2017-2023) Chapter ##.

  • Cancer Immunotherapy
  • Therapy
  • North America
  • United States
  • Market Size

Global Cancer Immunotherapy Drugs Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023 ##.

  • Cancer Immunotherapy
  • Therapy
  • World
  • Market Size

Cancer Immunotherapy: Payer Insight ##.

  • Cancer Immunotherapy
  • Therapy
  • United Kingdom
  • United States
  • Demand
  • C) Pipeline by cancer immunotherapy target
  • CANCER VACCINES, GLOBAL, ALL PIPELINE PRODUCTS, 2016

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer is anticipated to become increasingly prevalent due to aging populations and rising levels of obesity in the developed world. Cancer vaccines...

  • Cancer
  • Cancer Immunotherapy
  • Cell Therapy
  • Therapy
  • Vaccine
  • B) PIPELINE BY CANCER IMMUNOTHERAPY MOA
  • UROLOGIC ONCOLOGY THERAPEUTICS MARKET, GLOBAL, PIPELINE FOR KEY ONCOLOGY

Global Urological Cancer Market to 2022 - Strong Growth Driven by Rising Prevalence, Increased Uptake of Hormone Therapies and Approval of Novel Biologics Summary Urological cancers are thought to account for 19.5% of global cancer prevalence, with kidney, prostate, testicular and bladder cancer – the key indications covered...

  • Cancer Immunotherapy
  • World
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Pfizer Inc.

Global Cancer Immunotherapy Market Outlook 2020 ##.

  • Cancer Immunotherapy
  • Therapy

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 ##.

  • Biological Therapy
  • Cancer Immunotherapy
  • Cell Therapy
  • Therapy
  • World
  • 7. Global Cancer Vaccines Market - Major Deals

DCVAC/ PCa ##.

  • Cancer Immunotherapy
  • World
  • Altor BioScience Corporation
  • GlobeImmune, Inc.
  • Merck & Co., Inc.

Transforming Cancer Treatment with Immunotherapy (TechVision) ## EXECUTIVE SUMMARY Executive Summary ## Scope ## CANCER IMMUNOTHERAPY SNEAK PEAK Cancer Immunotherapy Sneak Peak ## Cancer: A growing global threat ## Care transformation across cancer ##

  • Cancer Immunotherapy
  • Therapy
  • World
  • IN THE CANCER IMMUNOTHERAPY MARKET
  • CANCER IMMUNOTHERAPY MARKET, BY PRODUCT TYPE

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, rising healthcare expenditure, and increased access to medical insurance in developed countries are driving growth in the caner...

  • Cancer Immunotherapy
  • Oncology
  • North America
  • United States
  • Market Size

Road Ahead: Dendritic Cell Cancer Vaccine in the Challenging Horizon of Cancer Immunotherapy ##.

  • Biological Therapy
  • Cancer Immunotherapy
  • Cell Therapy
  • Therapy

Cancer Immunotherapy Market & Clinical Pipeline Insight ##.

  • Cancer
  • Cancer Immunotherapy
  • Therapy
  • Market Size

Many government initiatives are encouraging researchers to develop cancer immunotherapies.

  • Cancer Immunotherapy
  • Therapy
  • Vaccine
  • World
  • Market Shares

Personalized Vaccine: Trail Towards Cancer ##. ## Prologue to Personalized Cancer Immunotherapy ##. ## Advent of Personalized Cancer Vaccine ##.

  • Cancer Immunotherapy
  • Therapy
  • Vaccine

This is the underlying principle of cancer immunotherapy.

  • Cancer Immunotherapy
  • Therapy

This was carried out to enhance its next generation cancer immunotherapy product pipeline

  • Cancer Immunotherapy
  • Therapy
  • United States
  • Forecast